Total Positions
52
Quarter
2025 Q4
Top Holding
INSM (11.9%)
Top 10 Concentration
67.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 52
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
INSM
INSMED INC
|
Healthcare | 11.86% | 13.11% |
#1
Prev: #1
|
4.7 | -2,323 | -0.5% |
P
S
|
489,482 | $85,189,447 | 2011 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FOLD
AMICUS THERAPEU...
|
Healthcare | 10.32% | 7.83% |
#2
2
Prev: #4
|
4.1 | -162,031 | -3.0% |
P
S
|
5,205,767 | $74,130,122 | 2007 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PTCT
PTC THERAPEUTIC...
|
Healthcare | 9.56% | 9.80% |
#3
1
Prev: #2
|
5.8 | 41,303 | 4.8% |
P
S
|
903,916 | $68,661,459 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 9.24% | 9.74% |
#4
1
Prev: #3
|
5.7 | 17,347 | 0.7% |
P
S
|
2,484,031 | $66,348,468 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 6.17% | 7.56% |
#5
Prev: #5
|
2.5 | -7,751 | -1.0% |
P
S
|
746,256 | $44,349,994 | 2004 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ANAB
ANAPTYSBIO INC
|
Healthcare | 4.66% | 3.82% |
#6
2
Prev: #8
|
3.9 | 16,512 | 2.5% |
P
S
|
690,032 | $33,452,751 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BIIB
BIOGEN INC
|
Healthcare | 4.50% | 4.81% |
#7
1
Prev: #6
|
1.8 | -2,090 | -1.1% |
P
S
|
183,571 | $32,306,660 | 2004 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 4.01% | 2.96% |
#8
3
Prev: #11
|
3.7 | 209,523 | 16.6% |
P
S
|
1,472,197 | $28,796,173 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 3.95% | 4.51% |
#9
2
Prev: #7
|
1.6 | no change | no change |
P
S
|
58,186 | $28,351,129 | 2007 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 3.51% | 2.74% |
#10
2
Prev: #12
|
3.5 | 93,156 | 41.5% |
P
S
|
317,456 | $25,209,181 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IOVA
IOVANCE BIOTHER...
|
Healthcare | 2.70% | 3.06% |
#11
2
Prev: #9
|
1.1 | -501,456 | -6.6% |
P
S
|
7,116,676 | $19,428,525 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NVCR
NOVOCURE LTD
|
Healthcare | 2.34% | 3.00% |
#12
2
Prev: #10
|
2.9 | 42,805 | 3.4% |
P
S
|
1,298,964 | $16,795,605 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 2.32% | 1.86% |
#13
5
Prev: #18
|
3.0 | 139,577 | 21.3% |
P
S
|
794,507 | $16,692,592 | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GOSS
GOSSAMER BIO IN...
|
Healthcare | 1.93% | 2.66% |
#14
Prev: #14
|
0.8 | -992,757 | -18.2% |
P
S
|
4,471,592 | $13,861,935 | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CMPX
COMPASS THERAPE...
|
Healthcare | 1.89% | — |
#15
Prev: #—
|
2.8 | 2,532,419 | no change |
NEW
|
2,532,419 | $13,599,090 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRTA
PROTHENA CORP P...
|
Healthcare | 1.76% | 2.39% |
#16
1
Prev: #15
|
0.7 | -3,518 | -0.3% |
P
S
|
1,320,510 | $12,610,871 | 2013 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MIRM
MIRUM PHARMACEU...
|
Healthcare | 1.72% | 0.88% |
#17
7
Prev: #24
|
3.0 | 91,721 | 141.8% |
P
S
|
156,421 | $12,355,695 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ANNX
ANNEXON INC
|
Healthcare | 1.67% | — |
#18
Prev: #—
|
2.7 | 2,384,192 | no change |
NEW
|
2,384,192 | $11,968,644 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 1.48% | 2.06% |
#19
3
Prev: #16
|
2.7 | 91,763 | 24.8% |
P
S
|
461,294 | $10,609,762 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DNLI
DENALI THERAPEU...
|
Healthcare | 1.47% | 1.10% |
#20
Prev: #20
|
2.8 | 233,233 | 57.2% |
P
S
|
641,239 | $10,586,856 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CDNA
CAREDX INC
|
Healthcare | 1.25% | 0.85% |
#21
4
Prev: #25
|
2.7 | 162,016 | 51.2% |
P
S
|
478,220 | $9,009,665 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EHTH
EHEALTH INC
|
Financial Services | 0.98% | 1.23% |
#22
3
Prev: #19
|
0.4 | -13,190 | -0.9% |
P
S
|
1,531,429 | $7,044,573 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 0.94% | 1.02% |
#23
1
Prev: #22
|
2.5 | 58,622 | 31.9% |
P
S
|
242,560 | $6,786,829 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CAPR
CAPRICOR THERAP...
|
Healthcare | 0.91% | — |
#24
Prev: #—
|
2.4 | 226,304 | no change |
NEW
|
226,304 | $6,531,133 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TSHA
TAYSHA GENE THE...
|
Healthcare | 0.91% | 0.75% |
#25
1
Prev: #26
|
0.4 | -62,838 | -5.0% |
P
S
|
1,183,195 | $6,507,573 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALNY
ALNYLAM PHARMAC...
|
Healthcare | 0.00% | 2.73% |
Sold All 😨
(Was: #13) |
0.3 | -32,320 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RNA
AVIDITY BIOSCIE...
|
Healthcare | 0.00% | 0.89% |
Sold All 😨
(Was: #23) |
0.3 | -109,831 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GBIO
GENERATION BIO ...
|
Healthcare | 0.00% | 0.02% |
Sold All 😨
(Was: #44) |
0.3 | -15,047 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 52 holdings